Intuitive Surgical entered the Q3 2026 report priced for perfection, trading on a rich 51.1x P/E and coming off a roughly 29% gain over the past three months. The stock then slipped about 2% after the release, even as quarterly revenue reached about US$3.0b and non GAAP earnings per share landed at US$3, with non GAAP operating margin around 42%. The market focused on a softer margin trend and the fresh US$450m litigation charge, while the core robotic surgery engine continued to generate strong recurring revenue and rising procedure volume.
Love Intuitive Surgical’s recurring procedure engine but concerned about rich valuation and fresh litigation charges eating into profitability? Compare that story with a curated set of stronger balance sheet and fundamentals stocks in our list of solid balance sheet and fundamentals stocks (25 results).
Q3 2026 Earnings Summary
- Revenue (Q3 2026 vs. Q3 2025): US$3,048.7m vs. US$2,505.1m (up about 22%)
- Net Income excl. extra items (Q3 2026 vs. Q3 2025): US$522.8m vs. US$704.4m (down about 26%)
- Basic EPS (Q3 2026 vs. Q3 2025): US$1.50 vs. US$1.98 (down about 24%)
- Non GAAP Operating Margin (Q3 2026 vs. prior period commentary): about 42% of revenue, with management highlighting a softer margin trend and the impact of a US$450m litigation charge on reported profitability
Ask Charlie what Intuitive Surgical’s new pricing means for growth.
Evaluating Intuitive Surgical’s Recurring Engine Against Q3
The bullish story hangs on Intuitive Surgical turning procedure growth and a larger installed base into a self reinforcing ecosystem.
"Bullish analysts expect Intuitive Surgical to use global procedure growth, a larger installed base, and high recurring revenue to keep expanding its da Vinci and Ion ecosystems over time."
Q3 goes a long way toward that milestone. Worldwide procedures rose about 15% with Ion up 31%, system installs increased 13% and da Vinci placements climbed 28%. Recurring streams reached 84% of revenue. Non GAAP operating margin held near 42% despite cost pressure and a large litigation charge on GAAP results, so the economics behind that ecosystem are still intact in the current numbers.
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for.
Intuitive Surgical Bear Case: Margin Strain Goes From Theory To Data
Bearish investors argue that Intuitive Surgical’s moat is eroding as rivals and hospital cost pressure chip away at profitability.
"Bearish analysts expect Intuitive Surgical to experience sustained margin pressure as pricing competition, policy headwinds and new robotic entrants compress returns on its growing installed base."
Q3 results give that concern more bite. Non GAAP operating margin held near 42%, yet guidance now bakes in lower gross margin, China is set for explicit I&A price cuts, and management plans 3 to 5% lower revenue per procedure from extended use instruments. The US$450m settlement tied to third party service disputes underlines recurring revenue vulnerability rather than easing it.
Hunt For Mispriced Cash Engines
Intuitive Surgical delivered strong recurring revenue in Q3 while investors questioned margin pressure and litigation costs. The real opportunity is finding stocks that could be undervalued before the market reassesses their cash generation.
- Company 1 - 31% below our estimate - targets higher margin service work as operational programs reshape its product mix toward power and nuclear projects.
- Company 2 - 47% below our estimate - supplies reinforcing products that ride infrastructure funding as engineered structural mesh gains share in large concrete and data center builds.
- Company 3 - 21% below our estimate - equips high density data centers with liquid cooling and power systems that become essential as AI hardware pushes beyond air cooling limits.
That is three of the list. See all 33 potentially undervalued companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com